Comparison Trial for Chloraprep Versus Aqueous Chlorhexidine (2%) for the Prevention of Catheter-related Bacteremia
Status:
Withdrawn
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
A multicentre, open-label clinical trial of two groups comparing cutaneous asepsis with
chlorhexidine gluconate at 2% + isopropyl alcohol 70% in relation to the placement of central
venous catheters (Study group) with standard asepsis with aqueous chlorhexidine at 2% (Group
Control). The incidence of catheter related bacteremia, the incidence of colonization of the
skin and the incidence of colonization of the central venous catheter will be evaluated.